| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5382600 (Pediatric) | UPJOHN | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
Sep, 2012
(11 years ago) | |
Detrol is owned by Upjohn.
Detrol contains Tolterodine Tartrate.
Detrol has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Detrol are:
- US5382600*PED
Detrol was authorised for market use on 25 March, 1998.
Detrol is available in tablet;oral dosage forms.
The generics of Detrol are possible to be released after 25 September, 2012.
Drugs and Companies using TOLTERODINE TARTRATE ingredient
Market Authorisation Date: 25 March, 1998
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of DETROL before it's drug patent expiration?
More Information on Dosage
DETROL family patents
